Population-Level Multiomics for Precision Medicine

Integrating human genomics and proteomics can help elucidate disease mechanisms, identify clinical biomarkers and discover drug targets.
In this webinar, you’ll hear how analyzing samples from over 50,000 UK Biobank participants with Olink Explore uncovered links between rare genetic variants and nearly 3,000 plasma proteins.

Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.

• Learn how Olink Explore data is now being combined with genomics at the population scale
• Understand how this combination of omics technologies provides unique insights into disease biology
• Discover the vital role played by rare variants in the regulation of protein levels and biological outcomes

Speaker

Ryan Dhindsa, M.D., Ph.D., Assistant Professor, Baylor College of Medicine